The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Brief ReportFull Access

Association Between Novelty Seeking and the Type 4 Dopamine Receptor Gene in a Large Finnish Cohort Sample

Published Online:https://doi.org/10.1176/ajp.156.9.1453

Abstract

OBJECTIVE: An association between the type 4 dopamine receptor (DRD4) gene and the behavioral trait of novelty seeking has been reported, but several studies have failed to replicate this finding. In the present study, the authors tested for this association in a representative sample from the Finnish population. METHOD: The authors administered the Temperament and Character Inventory to 4,773 individuals from the 1966 birth cohort of northern Finland. They then genotyped 190 subjects with extreme scores for a 48 base-pair repeat polymorphism in the DRD4 gene. RESULTS: There was a significant difference in allele frequencies between the two groups. The 2- and 5-repeat alleles were significantly more common in the group of high scorers than in the group of low scorers. CONCLUSIONS: These results confirm the original findings of an association between the DRD4 gene and novelty seeking, while showing that novelty seeking is probably not influenced by the polymorphism itself but, rather, a different DNA variant in the DRD4 gene or another gene in linkage disequilibrium with it.

An association between a polymorphism in the type 4 dopamine receptor gene (DRD4) and the behavioral trait of novelty seeking (1) has been reported (2, 3). In the original articles, high novelty seeking scores were associated with the 7-repeat allele of this functional 48bp repeat polymorphism. Multiple replication studies have failed to confirm the finding (48) or yielded only weak support for it (911). Some studies (4, 5) found associations between the 7-repeat allele and low novelty seeking scores in analyses of certain subgroups of the population studied. The objective of our study was to confirm or refute the findings through use of a large, general population-based birth cohort sample.

METHOD

Within the framework of the 1966 Northern Finland birth cohort study (12), 4,773 individuals completed the Temperament and Character Inventory (13) and gave a blood sample in accordance with the Helsinki declaration. We selected 50 men and 50 women with extremely high scores on the novelty seeking subscale of the Temperament and Character Inventory and the same number of subjects with extremely low scores. Written informed consent was obtained after written and verbal description of the study to the subjects.

Polymerase chain reaction was performed as described by Lichter et al. (14), with slight modifications. One primer was fluorescently labeled with Cy5 for size separation on an automated DNA sequencer (ALF express, Pharmacia Biotech AB). Genotyping was done through use of the Allelinks (Pharmacia Biotech AB) software.

Association between high or low scorer group status and the DRD4 allele frequencies was tested by using the Pearson chi-square statistic. For each allele we also calculated the chi-square statistic for presence versus absence of the allele in the individuals belonging to the low and high scoring groups.

RESULTS

The mean novelty seeking score was 20.3 (SD=5.9; 95% confidence interval=20.2–20.5). All the subjects included in the analysis had novelty seeking scores more than one standard deviation from the mean of the cohort (low scorers ≤12, high scorers ≥31), and the means for the groups with extreme scores (7.48 and 33.48, respectively) lay outside 1.96 standard deviations from the mean for the whole cohort.

The allele frequencies in the groups of extreme high and extreme low scorers are shown in table 1. The single 8-repeat allele was pooled with the 7-repeat allele in all analyses. For 10 individuals the DNA did not amplify, and they were excluded in all analyses.

There was a significant difference in allele frequencies between the groups (χ2=14.1, df=4, p=0.007), and the largest proportional differences in allele frequencies between the groups were observed for the 2- and 5-repeat alleles that were more common in the high scoring group (table 1). When comparing subjects grouped on the basis of presence or absence of each allele, i.e., treating genotypes rather than alleles as observations, we observed significant associations between high novelty seeking scores and the presence of the 2-repeat (χ2=6.1, df=1, p=0.01) and 5-repeat (χ2=5.0, df=1, p=0.03) alleles. The results for the other alleles were nonsignificant.

DISCUSSION

This is in several respects a more robust study than those published earlier. First, the subjects represent a large birth cohort rather than subjects selected for a known psychiatric diagnosis (4, 5, 8), level of education (2, 10), or sexual orientation (3) studied in some earlier reports. Second, the study subjects were stratified according to the novelty seeking scores, and the groups were compared with respect to genotype. In most earlier studies (2, 3, 46, 811), the strategy has been the reverse. Third, the study cohort was collected from a genetically isolated population, ideal for association studies.

The chi-square method that we used to test for any difference in allele frequencies between the groups has the obvious advantage that only one testing is performed, and the p value obtained needs not be corrected. However, it has been proposed that the method might overestimate the significance level if the locus studied is not truly codominant (15). Therefore, we also compared individuals with and without each allele. In contrast to the original reports, this analysis showed that the presence of the 2- and 5-repeat alleles is significantly associated with high novelty seeking scores in the Finnish population. There are a few possible explanations for this difference. First, it is possible that the studied polymorphism does not influence novelty seeking scores. The primary incentive to study this polymorphism was that it is a biologically reasonable candidate locus with functional differences between the different alleles (2, 3). However, our results show that novelty seeking score is, rather, influenced by a different variant in the DRD4 gene or by another gene in linkage disequilibrium. If this is the case, the gene influencing novelty seeking score could be in linkage disequilibrium with a different allele of the studied polymorphism in the Finnish population than in the other populations studied.

Second, it is possible that by selecting from the population those individuals with extreme scores, we have included a greater proportion of subjects with diagnosable personality disorders in the analysis. It is therefore possible, although unlikely, that the polymorphism studied is primarily associated with any such disorder and only secondarily associated with novelty seeking scores. Our study design cannot rule out that possibility, but since it is widely accepted that personality disorders can be conceptualized as extreme variants of normally distributed personality traits (16), we feel that our result is still valid.

Finally, even though our subjects are all the same age and represent a highly genetically and culturally homogeneous population, there is still a small chance of selection bias. This possibility will be excluded only by additional, preferably family-based, studies.

Received Sept. 8, 1998; revision received Feb. 9, 1999; accepted March 11, 1999. From the Department of Human Molecular Genetics, National Public Health Institute, Helsinki, Finland; and the Departments of Public Health and General Medicine, University of Oulu, Oulu, Finland. Address reprint requests to Dr. Peltonen, UCLA School of Medicine, Department of Human Genetics, Gonda Center, 695 Charles E. Young Dr. South, Box 708822, Los Angeles, CA 90095-7088. Supported by Finska Läkaresällskapet, the Hjelt Foundation, the University of Oulu, the Ministry of Health and Social Affairs of Finland, and an exchange program for German and Finnish researchers jointly funded by Deutscher Akademischer Austauschdienst and the Academy of Finland. The authors thank Mr. Pasi Korhonen for statistical advice and Ms. Jenni Leppävuori for double-checking the genotypes.

TABLE 1

References

1. Cloninger CR: A systematic method for clinical description and classification of personality variants: a proposal. Arch Gen Psychiatry 1987; 44:573–588Crossref, MedlineGoogle Scholar

2. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH: Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet 1996; 12:78–80Crossref, MedlineGoogle Scholar

3. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH: Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet 1996; 12:81–84Crossref, MedlineGoogle Scholar

4. Malhotra AK, Virkkunen M, Rooney W, Eggert M, Linnoila M, Goldman D: The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. Mol Psychiatry 1996; 1:388–391MedlineGoogle Scholar

5. Gelernter J, Kranzler H, Coccaro E, Siever L, New A, Mulgrew CL: D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder and control subjects. Am J Hum Genet 1997; 64:1144–1152Google Scholar

6. Jönsson EG, Nöthen MM, Gustavsson P, Neidt H, Brené S, Tylec A, Propping P, Sedvall GC: Lack of evidence for allelic association between personality traits and the dopamine D4 receptor gene polymorphisms. Am J Psychiatry 1997; 154:697–699LinkGoogle Scholar

7. Vanderbergh DJ, Zonderman AB, Wang J, Uhl JR, Costa PT Jr: No association between novelty seeking and dopamine D4 receptor (D4DR) exon III seven repeat alleles in Baltimore Longitudinal Study of Aging participants. Mol Psychiatry 1997; 2:417–419Crossref, MedlineGoogle Scholar

8. Sullivan PF, Fifield WJ, Kennedy MA, Mulder RT, Sellman JD, Joyce PR: No association between novelty seeking and the type 4 dopamine receptor gene (DRD4) in two New Zealand samples. Am J Psychiatry 1998; 155:98–101LinkGoogle Scholar

9. Ebstein RP, Nemanov L, Klotz I, Gritsenko I, Belmaker RH: Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of novelty seeking. Mol Psychiatry 1997; 2:472–477Crossref, MedlineGoogle Scholar

10. Ono Y, Manki H, Yoshimura K, Muramatsu T, Mizushima H, Higuchi S, Yagi G, Kanba S, Asai M: Association between dopamine D4 receptor (D4DR) exon III polymorphism and novelty seeking in Japanese subjects. Am J Med Genet 1997; 47:501–503CrossrefGoogle Scholar

11. Noble EP, Ozkaragoz TZ, Ritchie TL, Zhang X, Belin TR, Sparkes RS: D2 and D4 dopamine receptor polymorphisms and personality. Am J Med Genet Neuropsychiatr Genet 1998; 81:257–267Crossref, MedlineGoogle Scholar

12. Jones PB, Rantakallio P, Hartikainen A-L, Isohanni M, Sipila P: Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 North Finland general population birth cohort. Am J Psychiatry 1998; 155:355–364LinkGoogle Scholar

13. Cloninger CR, Przybeck TR, Svrakic DM, Wentzel RD: The Temperament and Character Inventory (TCI): A Guide to Its Development and Use. St Louis, Washington University, Center of Psychobiology of Personality, 1994Google Scholar

14. Lichter JB, Barr CL, Kennedy JL, Van Tol HHM, Kidd KK, Livak KJ: A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 1993; 2:767–773Crossref, MedlineGoogle Scholar

15. Sasieni PD: From Genotypes to Genes: Doubling the Sample Size. Biometrics 1997; 53:1253–1261Google Scholar

16. Battaglia M, Przybeck TR, Bellodi L, Cloninger CR: Temperament dimensions explain the comorbidity of psychiatric disorders. Compr Psychiatry 1996; 37:292–298Crossref, MedlineGoogle Scholar